David Dean
About David Dean
David Dean is the Chief Business Development Officer with extensive experience in finance, healthcare investment, and drug license agreements.
Chief Business Development Officer at Correvio
David Dean most recently served as the Chief Business Development Officer at Correvio. In this role, he was responsible for identifying business opportunities, conducting detailed analyses and valuations, and leading negotiations. He managed the drafting and finalization of multiple drug license agreements, demonstrating his expertise in the pharmaceutical sector and business development.
Business Development Experience
David Dean has extensive experience in business development, particularly in the healthcare and pharmaceutical sectors. He has successfully handled in and out-licensing transactions, mergers and acquisitions, as well as significant divestments. His ability to identify, negotiate, and execute complex transactions has been central to his career and business success.
Director and Research Analyst at Investment Bank
Before his tenure at Correvio, David Dean was a Director and Research Analyst at Canada’s largest independent investment bank. During his time there, he identified healthcare investment opportunities and played a key role in managing relationships for the bank. His work included in-depth research and analysis, adding substantial value to the investment bank's portfolio.
Educational Background
David Dean holds a Master of Business Administration in finance from Queen’s University, providing him with a strong foundation in financial management. He also earned a Master of Science in physiology from the Department of Medicine at the University of Ottawa, equipping him with a deep understanding of medical and physiological principles, which he has leveraged in his business development career.